| abstract |
A regulator of calcineurin based on a splice variant of the catalytic subunit of calcineurin is provided. Preferably, the catalytic subunit is the β, γ and / or α form of this subunit. The invention is for the treatment of regulators and, preferably, diseases associated with impaired calcineurin activity. Activators include substances that affect the stimulatory activity of the regulator. |